Biotech news covering gene therapy, CRISPR, drug development, medical devices, and the biotechnology companies advancing human health and agriculture.
Arizona State's Matthias Heyden has built a simulation method that pulls out the slow vibrations governing how proteins change shape, compressing weeks of compute into one overnight run.
Rocket Pharma's Kresladi received FDA accelerated approval on March 26, 2026, as the first gene therapy for Severe LAD-I, an immune disorder that is fatal in most untreated infants.
Washington University's Dr. Jeffrey Gordon received the $25,000 Gabbay Award for 30 years of microbiome science, including MDCF trials in Bangladesh showing measurable improvements in malnourished children.
A biotech company is testing a novel approach to produce pharmaceutical drugs inside chicken eggs, building on decades of egg-based vaccine manufacturing to slash production costs.
From Oxford spinouts to Cambridge genomics firms, 17 UK biotech startups are driving innovation in drug development, diagnostics, and precision medicine across Europe's most vibrant biotech hub.
The 25 largest public biotech companies lost market capitalization for the second time in three years, even as GLP-1 drugs and gene therapies reshape the industry pipeline.
